SEARCH BY TOPIC:

Find the content you are looking for on Diabetech by searching the desired device, company, or topic.

Nov 6, 2025

•

3 min read

Eversense 365 CGM is Submitted for CE Mark Approval

The regulatory milestone positions Eversense 365 for a 2026 European launch and marks a major step forward in long-term glucose monitoring technology.

Itzel Estrada

ŌURA and Tidepool Join Forces to Advance Diabetes Research

Nov 4, 2025

•

3 min read

ŌURA and Tidepool Join Forces to Advance Diabetes Research

The collaboration will link wearable, sleep, and menstrual cycle data with glucose trends to close long-standing gaps in women’s health and diabetes research.

Itzel Estrada

How RenewRx Aims to Rebuild Diabetes Management During Pregnancy

Nov 3, 2025

•

2 min read

How RenewRx Aims to Rebuild Diabetes Management During Pregnancy

RenewRx aims to fill the gaps left by the healthcare system to support providers and mothers manage gestational, type 1, and type 2 diabetes.

Team Diabetech

The Future of CGM Tech: Implantables, Brainwaves, and Beyond

Oct 31, 2025

•

3 min read

The Future of CGM Tech: Implantables, Brainwaves, and Beyond

A new generation of glucose monitors are in development — from long-term implantables to non-invasive sensors — promising faster, more seamless diabetes management.

Diabetech Justin

Tandem’s t:slim X2 Pump Officially Integrates the FreeStyle Libre 3 Plus CGM in the U.S.

Oct 29, 2025

•

3 min read

Tandem’s t:slim X2 Pump Officially Integrates the FreeStyle Libre 3 Plus CGM in the U.S.

All U.S. t:slim X2 users have access to FreeStyle Libre 3 Plus CGM integration, with international early-access programs rolling out later this year.

Diabetech Justin

California Caps Monthly Insulin at $35 and Launches $11 CalRx Insulin Pens to Tackle Drug Costs

Oct 29, 2025

•

2 min read

California Caps Monthly Insulin at $35 and Launches $11 CalRx Insulin Pens to Tackle Drug Costs

New laws and state-run manufacturing aim to make insulin more affordable to all Californians starting in 2026, setting a national example for diabetes care reform.

Itzel Estrada